Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiol- and metal-dependent enzymes are a broad class of proteins that utilize specific chemical groups or inorganic ions to catalyze biochemical reactions (Source: Andreini et al., 2008, Journal of Proteome Research). Thiol-dependent enzymes typically feature a reactive cysteine residue in their active site, which acts as a nucleophile or a redox sensor (Source: Reddie & Carroll, 2008, Current Opinion in Chemical Biology). Metal-dependent enzymes, or metalloenzymes, incorporate metal ions like zinc, iron, or magnesium to stabilize substrates or facilitate electron transfer (Source: Holm et al., 1996, Chemical Reviews). These enzymes play fundamental roles in physiological processes such as extracellular matrix remodeling, signal transduction, and metabolic regulation (Source: Rawlings et al., 2018, Nucleic Acids Research). Dysregulation of these enzymes is linked to numerous pathologies, including cancer metastasis, chronic inflammation, and viral infections (Source: Bond & Butler, 1987, Annual Review of Biochemistry). Therapeutic strategies often involve small-molecule inhibitors that either covalently bind to the active-site thiol or coordinate with the essential metal ion (Source: Copeland, 2005, Evaluation of Enzyme Inhibitors in Drug Discovery). While highly effective, targeting these enzymes is challenging due to the high conservation of active-site architectures, which can lead to poor selectivity and adverse side effects (Source: Farina et al., 1999, Expert Opinion on Therapeutic Patents). Notable examples of drugs targeting this class include ACE inhibitors for hypertension and various protease inhibitors for infectious diseases (Source: PubChem; StatPearls).
Drugs targeting these enzymes typically function by either forming a covalent bond with a catalytic cysteine thiol (thiol-dependent) or by providing a ligand (such as a hydroxamate or carboxylate group) that coordinates to the active-site metal ion, thereby blocking substrate access and catalytic turnover (Source: Copeland, 2005; Gupta et al., 2020).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol- and metal-dependent enzymes.